Abstract
Background: Iron deficiency is a commonly encountered problem in pregnancy and a frequently observed cause of pregnancy-associated anemia. We longitudinally assessed the iron regulatory hormone hepcidin during gestation and postpartum and related hepcidin to conventional indicators of iron status and inflammation.
Methods: Thirty-one healthy pregnant women were included and 81 blood samples from the three trimesters, directly and 6 weeks postpartum were analyzed for hemoglobin, the iron parameters: iron, total iron binding capacity, transferrin saturation, ferritin, soluble transferrin receptor and hepcidin, and CRP and leucocytes as markers of inflammation.
Results: Hepcidin concentration decreased gradually from the first to the second and third trimester to undetectable levels (≤0.5 nmol/L) which was paralleled by decreasing hemoglobin levels and changes in iron parameters indicative for iron deficiency. During gestation hepcidin levels correlated with iron parameters, but not with inflammatory markers. Postpartum, hepcidin increased immediately to levels similar as assessed at early pregnancy.
Conclusions: We conclude that hepcidin levels were suppressed during the second and third trimester of pregnancy, which was likely determined by the occurrence of iron deficiency. These data give insight in iron homeostasis during normal pregnancy.
The authors would like to thank Siem Klaver for his assistance with sample collection and storage.
Conflict of interest statement
Authors’ conflict of interest disclosure: The authors stated that there are no conflicts of interest regarding the publication of this article.
Research funding: None declared.
Employment or leadership: None declared.
Honorarium: None declared.
References
1. Wheeler S. Assessment and interpretation of micronutrient status during pregnancy. Proc Nutr Soc 2008;67:437–50.10.1017/S0029665108008732Search in Google Scholar
2. Bothwell TH. Iron requirements in pregnancy and strategies to meet them. Am J Clin Nutr 2000;72:257S–64S.10.1093/ajcn/72.1.257SSearch in Google Scholar
3. Milman N. Prepartum anaemia: prevention and treatment. Ann Hemat 2008;87:949–59.10.1007/s00277-008-0518-4Search in Google Scholar
4. WHO. World Health Organization. Iron deficiency anaemia, assessment, prevention, and control: a guide for programme managers 2001. Available at: http://www.who.int/nutrition/publications/en/ida_assessment_prevention_control.pdf. Accessed 19 June, 2012.Search in Google Scholar
5. WHO. Worldwide prevalence of anaemia 1993–2005: WHO global database on anaemia 2008. Available at: http://whqlibdoc.who.int/publications/2008/9789241596657_eng.pdf. Accessed 19 June, 2012.Search in Google Scholar
6. Kroot JJ, Tjalsma H, Fleming RE, Swinkels DW. Hepcidin in human iron disorders: diagnostic implications. Clin Chem 2011;57:1650–69.10.1373/clinchem.2009.140053Search in Google Scholar
7. Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 2004;306:2090–3.10.1126/science.1104742Search in Google Scholar
8. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med 2005;352:1011–23.10.1056/NEJMra041809Search in Google Scholar
9. Rehu M, Punnonen K, Ostland V, Heinonen S, Westerman M, Pulkki K, et al. Maternal serum hepcidin is low at term and independent of cord blood iron status. Eur J Haematol 2010;85:345–52.10.1111/j.1600-0609.2010.01479.xSearch in Google Scholar
10. Toldi G, Stenczer Bz, Molvarec A, Takáts Z, Beko G, Rigó J, et al. Hepcidin concentrations and iron homeostasis in preeclampsia. Clin Chem Lab Med 2010;48:1423–6.10.1515/CCLM.2010.290Search in Google Scholar
11. Gyarmati B, Szabó E, Szalay B, Czuczy N, Toldi G, Cseh Á, et al. Serum maternal hepcidin levels 3 days after delivery are higher compared to those measured at parturition. J Obstet Gynaecol Res 2011;37:1620–4.10.1111/j.1447-0756.2011.01586.xSearch in Google Scholar
12. Finkenstedt A, Widschwendter A, Brasse-Lagnel CG, Theurl I, Hubalek M, Dieplinger H, et al. Hepcidin is correlated to soluble hemojuvelin but not to increased GDF15 during pregnancy. Blood Cells Mol Dis 2012;48:233–7.10.1016/j.bcmd.2012.02.001Search in Google Scholar
13. van Santen S, van Dongen-Lases EC, de Vegt F, Laarakkers CM, van Riel PL, van Ede AE, et al. Hepcidin and hemoglobin content parameters in the diagnosis of iron deficiency in rheumatoid arthritis patients with anemia. Arthritis Rheum 2011;63: 3672–80.10.1002/art.30623Search in Google Scholar
14. Punnonen K, Irjala K, Rajamaki A. Serum transferrin receptor and its ratio to serum ferritin in the diagnosis of iron deficiency. Blood 1997;89:1052–7.10.1182/blood.V89.3.1052Search in Google Scholar
15. Rasmussen S, Bergsj P, Jacobsen G, Haram K, Bakketeig LS. Haemoglobin and serum ferritin in pregnancy: a correlation with smoking and body mass index. Eur J Obstet Gynecol Reprod Biol 2005;123:27–34.10.1016/j.ejogrb.2005.02.012Search in Google Scholar
16. Beguin Y. Soluble transferrin receptor for the evaluation of erythropoiesis and iron status. Clin Chim Acta 2003;329: 9–22.10.1016/S0009-8981(03)00005-6Search in Google Scholar
17. Kroot JJ, Laarakkers CM, Geurts-Moespot AJ, Grebenchtchikov N, Pickkers P, van Ede AE, et al. Immunochemical and mass-spectrometry-based serum hepcidin assays for iron metabolism disorders. Clin Chem 2010;56:1570–9.10.1373/clinchem.2010.149187Search in Google Scholar
18. Available at http://www.hepcidinanalysis.com/documents/Hepcidinanalysis_SerumandPlasma_2011.pdf. Accessed 19 June, 2012.Search in Google Scholar
19. Galesloot TE, Vermeulen SH, Geurts-Moespot AJ, Klaver SM, Kroot JJ, van Tienoven D, et al. Serum hepcidin: reference ranges and biochemical correlates in the general population. Blood 2011;117:e218–25.10.1182/blood-2011-02-337907Search in Google Scholar
20. Larsson A, Palm M, Hansson LO, Axelsson O. Reference values for clinical chemistry tests during normal pregnancy. Br J Obstet Gynecol 2008;115:874–81.10.1111/j.1471-0528.2008.01709.xSearch in Google Scholar
21. Choi JW, Im MW, Pai SH. Serum transferrin receptor concentrations during normal pregnancy. Clin Chem 2000;46:725–7.10.1093/clinchem/46.5.725Search in Google Scholar
22. Milman N, Bergholt T, Byg KE, Eriksen L, Hvas AM. Reference intervals for haematological variables during normal pregnancy and postpartum in 434 healthy Danish women. Eur J Haematol 2007;79:39–46.10.1111/j.1600-0609.2007.00873.xSearch in Google Scholar
23. Mei Z, Cogswell ME, Looker AC, Pfeiffer CM, Cusick SE, Lacher DA, et al. Assessment of iron status in US pregnant women from the National Health and Nutrition Examination Survey (NHANES), 1999–2006. Am J Clin Nutr 2011;93:1312–20.10.3945/ajcn.110.007195Search in Google Scholar
24. Ganz T. Hepcidin and iron regulation, 10 years later. Blood 2011;117:4425–33.10.1182/blood-2011-01-258467Search in Google Scholar
25. Mor G, Cardenas I. The immune system in pregnancy: a unique complexity. Am J Reprod Immunol 2010;63:425–33.10.1111/j.1600-0897.2010.00836.xSearch in Google Scholar
26. Yang Q, Jian J, Katz S, Abramson SB, Huang X. 17beta-Estradiol inhibits iron hormone hepcidin through an estrogen responsive element half-site. Endocrinology 2012;153:3170–8.10.1210/en.2011-2045Search in Google Scholar
27. Hou Y, Zhang S, Wang L, Li J, Qu G, He J, et al. Estrogen regulates iron homeostasis through governing hepatic hepcidin expression via an estrogen response element. Gene 2012;511:398–403.10.1016/j.gene.2012.09.060Search in Google Scholar
28. Reveiz L, Gyte GM, Cuervo LG, Casasbuenas A. Treatments for iron-deficiency anaemia in pregnancy. Cochrane Database Syst Rev 2011(10):CD003094.10.1002/14651858.CD003094.pub3Search in Google Scholar
29. Yip R. Significance of an abnormally low or high hemoglobin concentration during pregnancy: special consideration of iron nutrition. Am J Clin Nutr 2000;72:272S–9S.10.1093/ajcn/72.1.272SSearch in Google Scholar
30. Roe MA, Collings R, Dainty JR, Swinkels DW, Fairweather-Tait SJ. Plasma hepcidin concentrations significantly predict interindividual variation in iron absorption in healthy men. Am J Clin Nutr 2009;89:1088–91.10.3945/ajcn.2008.27297Search in Google Scholar
31. Zimmermann MB, Troesch B, Biebinger R, Egli I, Zeder C, Hurrell RF. Plasma hepcidin is a modest predictor of dietary iron bioavailability in humans, whereas oral iron loading, measured by stable-isotope appearance curves, increases plasma hepcidin. Am J Clin Nutr 2009;90:1280–7.10.3945/ajcn.2009.28129Search in Google Scholar
32. Gangopadhyay R, Karoshi M, Keith L. Anemia and pregnancy: a link to maternal chronic diseases. Int J Gynaecol Obstet 2011;115 S1:S11–5.10.1016/S0020-7292(11)60005-2Search in Google Scholar
33. Northrop-Clewes CA. Interpreting indicators of iron status during an acute phase response-lessons from malaria and human immunodeficiency virus. Ann Clin Biochem 2008;45:18–32.10.1258/acb.2007.007167Search in Google Scholar
©2013 by Walter de Gruyter Berlin Boston